Opendata, web and dolomites

GOTBONE TERMINATED

Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GOTBONE project word cloud

Explore the words cloud of the GOTBONE project. It provides you a very rough idea of what is the project "GOTBONE" about.

locus    basis    trabecular    genetic    health    preclinical    determinants    clinical    remaining    huge    cohort    impaired    interaction    serum       hip    murine    least    bone    volumetric    complementary    cultures    drugs    representing    epidemiological    rheumatology    risk    cell    40    morphogenetic    translate    prevention    fracture    2014    academic    predicts    vertebral    assistant    lifetime    special    population    osteoarthritis    men    mortality    biology    mineral    grem2    professor    prospective    reducing    fragility    osteoporosis    burden    nature    modified    wnt    models    regulates    regulator    cortical    supervisor    skills    translational    15    fellowship    dependent    wnt16    density    background    3010    therapies    bmd    sustain    excellence    lipase    notum    spectrum    added    fractures    performed    women    medicine    career    economic    genetically    collaborations    regulating    lab    microarchitecture    mechanisms    thickness    osteoporotic    site    regulation    biomarkers    protein    antagonist    human   

Project "GOTBONE" data sheet

The following table provides information about the project.

Coordinator
GOETEBORGS UNIVERSITET 

Organization address
address: VASAPARKEN
city: GOETEBORG
postcode: 405 30
website: www.gu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website https://gup.ub.gu.se/publication/269257
 Total cost 185˙857 €
 EC max contribution 185˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET SE (GOETEBORG) coordinator 185˙857.00

Map

 Project objective

Osteoporosis is a major health concern characterized by reduced bone mineral density (BMD) and impaired microarchitecture leading to increased risk of fractures and mortality, especially at the hip. At least 40% of women and 15% of men will sustain one or more fragility fractures in their remaining lifetime, representing a huge economic burden in Europe. Currently available osteoporosis drugs are effective in reducing vertebral fracture risk (dependent on trabecular bone) while less effective for non-vertebral and hip fracture risk (dependent on cortical bone). This proposal aims to identify novel mechanisms regulating site-specific fracture risk, on the basis of recent human genetic findings on the determinants of cortical bone thickness (WNT16 locus) and trabecular volumetric BMD (GREM2 locus). This translational research program will study the role of the WNT lipase NOTUM in the regulation of cortical bone thickness via its interaction with WNT16, a key regulator of cortical bone identified by the proposed supervisor (Nature Medicine 2014). We will next study how the Bone Morphogenetic Protein antagonist GREM2 regulates trabecular BMD. These studies will be performed using genetically modified murine models and human cell-cultures systems. Finally, in a prospective population-based cohort study (n=3010), we will test if serum level of NOTUM predicts the risk of fractures. Our long term goal is to translate these findings into novel biomarkers and more effective therapies for the prevention of osteoporotic fractures. The applicant is an Assistant Professor of Rheumatology with a special clinical focus on osteoporosis and a complementary preclinical research background in osteoarthritis but not osteoporosis. This fellowship in a lab of excellence in the field of translational osteoporosis research will enhance his skills in both bone biology and epidemiological studies and will provide a huge added-value to his academic career with a spectrum of new collaborations.

 Publications

year authors and title journal last update
List of publications.
2018 Thomas Funck-Brentano, Karin H Nilsson, Robert Brommage, Petra Henning, Ulf H Lerner, Antti Koskela, Juha Tuukkanen, Martine Cohen-Solal, Sofia Movérare-Skrtic, Claes Ohlsson
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice
published pages: 13-23, ISSN: 0022-0795, DOI: 10.1530/JOE-18-0153
Journal of Endocrinology 238/1 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GOTBONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GOTBONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More  

MY MITOCOMPLEX (2021)

Functional relevance of mitochondrial supercomplex assembly in myeloid cells

Read More  

SymCO (2020)

Asymptotic Symmetries: from Concepts to Observations

Read More